Tirzepatide
First-in-class dual GIP/GLP-1 receptor agonist for metabolic research.
From · per box of 10 vials
$55
Long-acting GLP-1 receptor agonist research compound with 94% homology to native GLP-1.
Semaglutide is a long-acting GLP-1 receptor agonist used extensively in metabolic research as a reference compound for appetite regulation and glucose metabolism studies. Available in multiple vial sizes for dose-response analysis. For laboratory research use only.
Binds GLP-1 receptors, driving cAMP signaling, glucose-dependent insulin secretion, and hypothalamic appetite regulation.
STEP program trials reported substantial body weight reductions versus placebo; frequently used as a positive control in metabolic research.
Intended for research only. Handle as a potent investigational compound; use appropriate lab PPE and reconstitution protocols.
From $45
per box of 10 vials
| Code | Dose | Price (USD) | Actions |
|---|---|---|---|
| SM5 | 5 mg | $45 | |
| SM10 | 10 mg | $70 | |
| SM15 | 15 mg | $85 | |
| SM20 | 20 mg | $100 | |
| SM30 | 30 mg | $135 |
Research Use Only: All products are strictly intended for laboratory research and scientific analysis only. Not for human consumption, clinical use, or diagnostic applications.
First-in-class dual GIP/GLP-1 receptor agonist for metabolic research.
From · per box of 10 vials
$55
Triple agonist (GLP-1, GIP, glucagon) research compound for metabolic studies.
From · per box of 10 vials
$100
Dual GLP-1/glucagon receptor agonist research compound.
From · per box of 10 vials
$355
Triple agonist (GLP-1, GIP, glucagon) research compound for metabolic studies — box of 10 vials.
From · per box of 10 vials
$180